The Merck Accelerator program supports start-ups with the final objective of partnering up with them. Merck is looking for real partners so that we can work together in shaping the future. Selected companies receive mentoring and in-depth coaching from a network comprised of experts from 66 countries, opening up opportunities for start-ups’ future collaboration with Merck and helping to introduce startups to the contacts they need to close their first deals. Additionally, the start-up teams benefit from financial support, as well as from work space at the Merck Innovation Centre in Darmstadt, where they can develop product prototypes and exchange ideas with other start-up teams and Merck experts. More info here
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2018, Merck generated sales of €14.8 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly-listed company. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.